Price:$21.95 Free Shipping + Save up to 20%! Learn
more
Research Findings
and Key Ingredients
Beta-Carotene (15 mg, 25,000 IU)*
Beta-carotene functions primarily as a fat-soluble antioxidant. It can
also be converted to vitamin
A as needed by the body. The amount of beta-carotene
in MacularProtect is theoretically equivalent to 25,000 IU vitamin
A, although actual conversion rates vary with individual need.
Vitamin A is essential for proper eye health;
it protects night vision and is vital for the health of the eyes
cornea. It also works with zinc
to support the proper function of various eye structures. Vitamin
A serves an important role in interactions with zinc
and the amino acid taurine within the photoreceptors of the retina.
MacularProtect contains 15 mg of beta-carotene
in the same form and potency as that used in the AREDS
trial.
Vitamin C (1,000 mg) Vitamin C is a water-soluble antioxidant that is concentrated in ocular
tissues where it inactivates free radicals. Free radicals are the highly
reactive compounds produced through the bodys use of oxygen and
generated by outside sources such as UV light. Oxidative damage to the
retina is believed to be a risk factor for macular degeneration. As
an integral component of the bodys antioxidant defenses, vitamin
C also aids in the recycling of other antioxidants such as vitamin E.
MacularProtect supplies the form and level administered in AREDS, plus
an additional 500 mg.
Vitamin E (400 IU)
Fat soluble vitamin E is the major chain-breaking antioxidant present
in retinal and macular membranes. As a first line of defense against
fatty acid peroxidation, vitamin E helps protect cell membranes against
free radical attack through its free radical-scavenging activity. MacularProtect
provides the natural source rather than the synthetic form of vitamin
E, as studies demonstrate that this form offers superior bioavailability
and is better retained in tissues. It also delivers broad spectrum vitamin
E from alpha to gamma tocopherol, that together play a health-protective
role. MacularProtect includes 400 IU of vitamin E, the level administered
in the AREDS clinical trial.
Zinc (80 mg) Zinc
is an essential mineral that is selectively concentrated in the eye.
It is found in the retina and choroid, ciliary body, iris, optic nerve,
sclera, cornea and lens. Within these ocular structures zinc
is believed to interact with vitamin
A and taurine to modify photoreceptor membranes, to help regulate
the light-rhodopsin reaction, to influence nerve transmission and to
serve as an antioxidant. MacularProtect provides 80 mg of zinc
in the same form and level administered in the AREDS
clinical trial.
Copper (2 mg) Copper
is a mineral that is necessary for normal development of connective
tissue, nerve sheaths, skin pigment and for the proper utilization of
iron. Since high levels of zinc
compete with copper
for absorption, copper
is included in MacularProtect to help ensure an adequate level of this
essential mineral in the body. The amount of supplemental copper
in MacularProtect represents 100% of the Daily Value and is the form
and amount administered in the AREDS
clinical trial.
Lutein, FloraGLO® (10 mg)
and Zeaxanthin (1 mg)
Lutein and zeaxanthin are two similarly-structured carotenoids found
in green leafy vegetables like spinach, kale and mustard greens. These
carotenoids make up the macular pigment of the retina, the tissue with
the highest concentration of lutein and zeaxanthin in the body. As part
of the macular pigment, lutein and zeaxanthin filter blue (visible)
light that can induce photo-oxidative stress.
Population health studies have noted that
macular pigment density is positively associated with age-related macular
health. Several intervention studies also indicate that consumption
of these carotenoids from foods or supplements can favorably modify
the optical pigment density or thickness of the macula. The amount of
lutein supplied by MacularProtect Complete is consistent with that administered
in a one-year clinical trial which reported improvements in visual performance
for patients with AMD. The ratio of zeaxanthin to lutein within this
formula reflects the levels naturally present in the diet.
MacularProtect provides FloraGLO®
lutein, a premium source with proven bioavailability. Several studies
have found FloraGLO®
lutein to be as well or better absorbed than lutein from concentrated
food sources such as spinach and green leafy vegetables.
*
The level of beta-carotene studied in the AREDS
clinical trial and provided in MacularProtect is not recommended for
smokers and very recent ex-smokers. If you are a smoker or very recent
ex-smoker, you may want to consider MacularProtect
Complete®-S or MacularProtect
Plus®.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.